Colchicine vs. Omega-3 Fatty Acids for Prevention of Chronic Cyclosporine Nephrotoxicity in Sprague Dawley Rats: An Experimental Animal Model

Archives of Medical Research

Volumn 37, Issue 8, 2006, Pages 933-940

  Sabry, Alaa ^a   El Husseini, Amr ^a   Sheashaa, Hussien ^a   Abdel Shafy, Eid ^b   El Dahshan, Khaled ^a   Abdel Rahim, Mona ^a   Abdel Kaleek, Ehab ^a   Abo Zena, Hamdy ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b TANTA UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Cyclosporine; Experimental; Nephrotoxicity

Indexed keywords

COLCHICINE; CREATININE; CYCLOSPORIN; OLIVE OIL; OMEGA 3 FATTY ACID; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ANIMALS; COLCHICINE; CREATININE; CYCLOSPORINE; FATTY ACIDS, OMEGA-3; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; SODIUM; TUBULIN MODULATORS; VIMENTIN;

EID: 33749432925     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.07.001     Document Type: Article

References (27)

1. Padi S., and Chopra K. Selective angiotensin Π type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 45 (2002) 413-420
2. Woodward R.S., Kutinova A., Schnitzler M.A., and Brennan D.C. Renal graft survival and calcineurin inhibitor. Transplantation 80 (2005) 629-633
3. Li C., Yang C.W., Kim W.Y., Jung J.Y., Cha J.H., Kim Y.S., et al. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 284 (2003) 389-398
4. Bergstrand A., Bohmann S.O., and Fransworth A. Renal histopathology in kidney transplant recipients' immunosuppressed with cyclosporine A. Clin Nephrol 24 (1985) 107-119
5. Mervaala E., Lassila M., Vaskonen T., Krogerus L., Hteenma T., Vapaatalo H., et al. Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet. Blood Pressure 8 (1999) 49-56
6. Mervaala E.M., Pere A.K., Lindgren L., Laakso J., Teravainen T.L., Karjala K., et al. Effects of dietary sodium and magnesium on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. Hypertension 29 (1997) 822-827
7. Pere A.K., Krogerus L., Mervaala E.M., Laakso J., Karppanen H., Inkinen K., et al. Beneficial effect of dietary magnesium on glomerular changes in cyclosporin-A treated spontaneously hypertensive rats. Nephrol Dial Transplant 13 (1998) 904-910
8. Matsumoto T., Mizunoe Y., Sakamoto N., and Kumazawa J. Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pilli. Nephron 56 (1990) 130-135
9. McClurkin Jr. C., Phan S.H., and Hsu C.H. Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti-GBM disease in the rabbit. J Am Soc Nephrol 1 (1990) 257-265
10. Alexander J.W., Valente J.F., Greenberg N.A., Custer D.A., Ogle C.K., Gibson S.W., et al. Dietary omega-3 and omega-9 fatty acids uniquely enhance allograft survival in cyclosporine-treated and donor-specific transfusion-treated rats. Transplantation 27 (1998) 1304-1309
11. Homan van der Heide J.J., Bilo H.J., Tegzess A.M., and Donker A.J. The effect of dietary supplementation with fish oil on renal function in cyclosporine-treated transplant recipients. Transplantation 49 (1990) 523-527
12. Orme M.E., Jurewicz W.A., Kumar N., and McKechnie T.L. The cost effectiveness of tacrolimus vs. microemulsified cyclosporin: a 10-year model of renal transplantation outcomes. Pharmacoeconomics 21 (2003) 1263-1276
13. Capasso G., Rosatic C., Ciani F., Giordano D.R., Russo F., and De Santo N.G. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertens 3 (1990) 204-210
14. Darlametsos I.E., Papanikolaou E.N., and Varonos D.D. Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems. Prostaglandins Leukot Essent Fatty Acids 63 (2000) 263-269
15. Conger J.D., Kim G.E., and Robinette J.B. Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 267 (1994) 443-449
16. Curtis L. Misoprostol in renal transplantation. Transplant Proc 25 (1993) 602
17. El-Shanti H., Majeed H.A., and El-Khateeb M. Familial mediterranean fever in Arabs. Lancet 367 (2006) 1016-1024
18. Sobh M., Moustafa F., Hamed S., and Ghoniem M. Study of the effect of colchicine on Schistosoma-induced renal amyloidosis in Syrian golden hamsters. Nephron 70 (1995) 478-485
19. Adam M. The Enisoprost Renal Transplant Study Group. Enisoprost in renal transplantation. Transplantation 53 (1992) 328-345
20. Ryffel B., Seigi H., Muller S., Donatsch P., Wilson J.T., and Mihatsch M.J. The rat as an experimental model of ciclosporin nephrotoxicity. Human Toxicol 3 (1984) 417
21. Mihatsch M.J., Theil G., and Ryffel B. Morphology of ciclosporin nephropathy. Prog Allergy 38 (1986) 444-465
22. Rosen S., Greenfeld Z., and Brezis M. Chronic cyclosporin-induced nephropathy in the rat. A medullary ray and inner strip injury. Transplantation 49 (1990) 445-452
23. Thomson A.W., Whiting P.H., and Simpson J.G. Cyclosporine, immunology, toxicity and pharmacology in experimental animals. Agent Actions 15 (1984) 306-327
24. El Zinga L.W., Rosen S., Porter G.A., and Bennet W.M. Persistence of chronic injury despite normalization of renal function in experimental ciclosporin nephrotoxicity. J Am Soc Nephrol 1 (1990) 610
25. Roberts W.N., Liang M.H., and Stien S.H. Colchicine in acute gout. Reassessment of risks and benefits. JAMA 527 (1987) 1920-1922
26. Muchaneata-Kubara E.C., and El Nahas A.M. Transdifferentiation of renal cells during experimental renal scarring. J Am Soc Nephrol 6 (1995) 903
27. Adam A., Goumenos D., Brown C.B., Shortland J., and El Nahas A.M. Phenotypic modulation of renal cells in the course of mesangiocapillary glomerulonephritis (MCGN). J Am Soc Nephrol 6 (1995) 108